Hot Movers: GTx, Inc. (NASDAQ:GTXI), Renren Inc (NYSE:RENN), Rockwell Medical Inc (NASDAQ:RMTI)
GTx, Inc. (NASDAQ:GTXI) stock declined 14.31% to $1.61. The company on Sept. 24 announced that top line results from the two Phase 3 trials on the effects of enobosarm for the prevention and treatment of muscle wasting in non-small cell lung cancer patients was presented on September 28, 2013, at the European Cancer Congress 2013 (September 27-October 1, 2013) in Amsterdam.
How Should Investors Trade GTXI After The Recent Volatility? Get Free Report Here
Renren Inc (NYSE:RENN) surged up 9.34% to $3.98 on a traded volume of 3.50 million shares. So far this year, the stock is up over 22%. The 52-week range for the stock is $2.52 and $4.62.
Is RENN A Good Buy After The Recent Price Movement? Find Out Here
Rockwell Medical Inc (NASDAQ:RMTI) moved up 6.99% to $12.24 on a traded volume of 3.39 million shares. Rockwell Medical, Inc. announced that the Phase 3 CRUISE-1 and CRUISE-2 clinical abstract submitted as a Late-Breaking Clinical Trial to the ASN LBCT subcommittee has been accepted for poster presentation at the ASN Kidney Week 2013 Annual Meeting, November 7-10 in Atlanta, GA.